At Brigham and Women’s Hospital, the cancer biologist is combining research into the tumor microenvironment with the principles of neuroscience to tease apart how cancers grow—and how to stop them.
Studies show that a fourth mRNA vaccine dose offers the elderly and other high-risk groups strong protection against hospitalization and death from COVID-19, but experts say benefits for other populations may be more limited.
Julie Lovchik will discuss how advanced flow cytometry instrumentation facilitates multiplex assessment of IgG, IgM, and IgA antibodies against SARS-CoV-2.
September’s crossword is just around the corner—have you finished August’s yet?
Thanks for reading! I'm Christie, and I curate and edit this newsletter. My inbox is always open, so if you have thoughts or ideas about this newsletter or tips for our news team, I'd love to hear from you.
Want More? We also offer curated newsletters that focus in on research areas, including Microbiology and Life.
Advertisement
Follow The Scientist
Never miss an email from The Scientist. Click hereto add The Scientist to your safe-sender list.
The Scientist,1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll-Free: (888) 781-0328 | Phone: (705) 528-6888 Email: privacy@the-scientist.com